2.56
2.56 (0%)
As of Feb 14, 2025
Macrogenics Inc [MGNX]
Source:
Company Overview
Macrogenics Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, manufacturing and commercializing innovative antibody-based therapeutics for the treatment of cancer. We generate our pipeline of product candidates from our proprietary suite of antibody technology platforms.
| Country | United States |
| Headquarters | rockville, maryland |
| Phone Number | (301) 251-5172 |
| Industry | manufacturing |
| CEO | Scott Koenig |
| Website | www.macrogenics.com |